Clinical Trial Update: Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14) [Phase 2]

View source ↗

Summary

Phase 2 trial of pomalidomide in combination with dexamethasone in multiple myeloma patients with Del(17p) or t(4;14) abnormalities; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: University Hospital, Lille | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED